Carpal tunnel syndrome has a substantial direct ESWT evidence base compared with many peripheral nerve conditions. Multiple randomized trials and several meta-analyses have evaluated shockwave for mild-to-moderate CTS using pain, Boston Carpal Tunnel Questionnaire scores, nerve-conduction studies and ultrasound measures of median-nerve cross-sectional area.
The overall evidence is favorable but not uniform. Some meta-analyses find clinically meaningful improvement, while others find that benefits over night splinting become small or nonsignificant after the early follow-up period. Newer studies also support ESWT as part of multimodal conservative care.
The most defensible conclusion is that ESWT is an evidence-supported noninvasive option for selected mild-to-moderate CTS—not a substitute for decompression when progressive motor loss or severe compression is present.
What the current shockwave evidence shows
2023 updated meta-analysis
19 randomized trials
in mild-to-moderate CTS, including both focused and radial ESWT
Improved
Symptoms and function
plus electrodiagnostic measures and median-nerve cross-sectional area
Evidence certainty
Low
rated with the GRADE approach
PMID 38068415. Supportive evidence, but protocols, comparators and follow-up periods varied substantially.
Start with the diagnosis and the severity
Shockwave evidence for carpal tunnel syndrome applies to carpal tunnel syndrome. Hand numbness can also come from pronator syndrome, cervical radiculopathy, the ulnar or radial nerve or a polyneuropathy, and those problems are not treated the same way. The differentials are covered in carpal tunnel vs pronator syndrome and carpal tunnel vs cervical radiculopathy.
Severity matters just as much. Conservative treatment evidence applies primarily to mild-to-moderate CTS. Progressive motor loss or severe nerve compression requires a different treatment pathway.
The 2023 updated meta-analysis
The largest dedicated review searched the literature through August 2023, included 19 randomized controlled trials of ESWT for mild-to-moderate carpal tunnel syndrome and rated the certainty of evidence with the GRADE approach (Zhang, 2023).
A 2023 updated meta-analysis of 19 randomized trials found low-certainty evidence that both focused and radial ESWT improved symptoms, function, electrophysiologic measures and median-nerve cross-sectional area in mild-to-moderate CTS.
The certainty of evidence was rated low, so the findings should be interpreted as supportive rather than definitive.
Against local corticosteroid injection, the review reported similar results in the short term (under one month) and better pain relief and functional recovery with ESWT at medium-term (one to six months) and long-term (over six months) follow-up. The same low-certainty caveat applies to that comparison.
Why the evidence still requires caution
An earlier meta-analysis asked a narrower question: does adding ESWT to night wrist splinting help more than splinting alone (Chen, 2022)? It included seven randomized trials with 376 participants and used an all-time-points analysis to look at trends over repeated measurements.
An earlier meta-analysis of seven randomized trials and 376 participants reached a more cautious conclusion: adding ESWT to night splinting produced early improvement at four weeks, but did not demonstrate consistent superiority at later follow-up.
The authors described the effect as transient and mostly nonsignificant compared with night splinting, and no serious side effects were reported in any included study.
Why the evidence still requires caution
2022 meta-analysis
7 RCTs, 376 participants
ESWT plus night splint vs night splint alone
Greater benefit
At 4 weeks
for symptom severity and functional impairment
No consistent superiority
Later on
at 8–10 weeks, 12–14 weeks or across all time points
PMID 35630095. Different review methods and treatment comparisons produce different estimates of ESWT benefit.
Why the meta-analyses disagree
The two reviews are not contradictory so much as they answer different questions. The 2023 review pooled 19 trials against a range of control interventions and separately compared ESWT with injection. The 2022 review restricted itself to trials where both groups wore a night splint, which is itself an effective treatment, so any added benefit from shockwave had to show up on top of it.
Other differences matter too:
- Trials used different comparators, from sham to splint-only to multimodal programs
- Some used radial devices and some focused devices, at different energy settings
- The number of sessions ranged from a few to several weeks of treatment
- Follow-up periods ranged from immediately after treatment to several months
- Severity mix and outcome measures varied
The disagreement between reviews is itself clinically informative: the ESWT effect appears sensitive to study design, comparator, protocol and follow-up interval.
Comparing conservative treatments
A 2025 network meta-analysis took a wider view and compared 11 conservative treatments for carpal tunnel syndrome across 49 randomized trials and 3,323 participants, including manual therapy, steroid injection, platelet-rich plasma, dextrose injection, ESWT and low-level laser therapy (Chen, 2025).
A 2025 network meta-analysis of 49 RCTs and 3,323 participants found a significant pain benefit for ESWT versus control (SMD -1.03; 95% CI -1.86 to -0.20). Manual therapy ranked highest for short- and medium-term pain relief.
Manual therapy had surface-under-the-curve ranking values of 87.6% for short-term and 99.3% for medium-term pain relief, with dextrose injection and platelet-rich plasma close behind. Low-level laser therapy also showed a significant benefit over control (SMD −1.45; 95% CI −2.16 to −0.74).
Network rankings do not prove that one intervention is universally superior, and the ESWT trials overlap with earlier meta-analytic literature. The practical message is that several conservative treatments help, and shockwave is one of them rather than the obvious first choice.
Conservative treatment comparison
Network
49 RCTs, 3,323 participants
11 conservative treatments compared
ESWT vs control
Pain SMD −1.03
95% CI −1.86 to −0.20
Ranked highest
Manual therapy
for short- and medium-term pain relief
PMID 40315975. Network rankings are probabilistic and do not establish universal treatment superiority.
Earlier reviews
Two earlier meta-analyses provide historical context. They overlap with the newer reviews and should not be counted as additional patients.
A 2019 meta-analysis of six randomized trials found a significant overall effect of ESWT compared with control (Hedges g SMD 1.447; 95% CI 0.439 to 2.456; p = .005), with improvement in symptoms, function and electrophysiologic parameters. It found no clear difference between ESWT and local corticosteroid injection (SMD 0.418; 95% CI −0.131 to 0.968; p = .135) (Kim, 2019).
A 2020 review of 10 trials with 433 patients and 501 wrists found significant benefits for pain (MD −0.60; 95% CI −1.16 to −0.05), symptoms (MD −2.26; 95% CI −3.24 to −1.27) and function (MD −1.25; 95% CI −2.08 to −0.43) (Xie, 2020). In subgroup analysis, the radial trials showed significant effects and the focused trials did not.
An earlier 10-trial meta-analysis reported significant pooled benefits for pain, symptoms and function and found stronger statistical signals in the radial subgroup. This should not be treated as proof that radial ESWT is biologically superior to focused ESWT.
New 2026 randomized evidence
A 2026 trial randomized 100 women aged 25 to 40 with mild-to-moderate CTS, confirmed clinically and with nerve-conduction studies, into two groups of 50 (Al-Afify, 2026). Both groups received the same six-week conventional program: median nerve and tendon gliding exercises, a neutral-position night wrist splint, ergonomic education and activity modification, and kinesiotaping. The experimental group also received radial ESWT over the carpal tunnel region, once weekly for six sessions, at 1 Hz and 60 mJ with 1,200 shocks per session.
A 2026 randomized trial of 100 women with mild-to-moderate CTS found that adding radial ESWT to a six-week conservative program produced greater improvement in symptom severity, pain and several nerve-conduction measures than conservative care alone. Functional-status and motor-conduction outcomes were not significantly different.
The trial included only women aged 25 to 40, measured outcomes at six weeks, and added ESWT to an active program rather than comparing it with sham.
New 2026 randomized evidence
Participants
100 women, 25–40
mild-to-moderate CTS; 50 conventional care, 50 conventional care plus radial ESWT
Radial ESWT
6 weekly sessions
1,200 shocks per session at 1 Hz and 60 mJ
Greater improvement
Symptoms and pain
plus distal sensory and motor latency and sensory conduction velocity; not motor conduction velocity or functional status
PMID 42332941. Female-only, younger adult population receiving multimodal background therapy.
A separate 2026 randomized trial of 54 people with mild-to-moderate CTS found improvement in all groups, with the multimodal ESWT-plus-taping group showing the largest gains (Kocaman, 2026). Participants received splinting and nerve-tendon gliding alone, the same plus ESWT, or the same plus ESWT and kinesiotaping. The design shows that the full multimodal package did best; it does not isolate what shockwave contributed on its own, and the abstract does not name the device type.
Ultrasound and nerve-conduction outcomes
A small randomized study comparing adjunctive ESWT with low-level laser therapy found reductions in pain and median-nerve cross-sectional area with both treatments and no clear between-group advantage (Ghasemi, 2024). Thirty-six patients were randomized to four ESWT sessions or ten laser sessions, each added to ten sessions of conventional therapy over two weeks, but only 18 patients who completed treatment were analyzed. The ESWT group's cross-sectional area fell by a mean of 1.2 (95% CI 0.51 to 1.9) and pain by 4.4 points (95% CI 3.6 to 5.3). With half the sample lost and no untreated control, the result is hypothesis-generating.
Some trials report a reduction in ultrasound-measured median-nerve cross-sectional area after treatment. That is a structural imaging outcome and should not be described as direct proof of mechanical decompression.
Nerve-conduction measures such as sensory and motor distal latency and conduction velocity assess nerve physiology objectively. ESWT trials report improvement in some electrodiagnostic measures, but effects are not uniform across every sensory and motor parameter. A 2024 meta-analysis of 22 trials of ESWT across peripheral nerve conditions found improvements in sensory distal latency and sensory conduction velocity, a short-term reduction in motor distal latency and no significant effect on motor conduction velocity; ESWT was better than control but not significantly better than local corticosteroid injection (Yang, 2024). Because it pooled several nerve conditions, its estimates are not carpal tunnel-specific.
How shockwave may work
The precise mechanism is not established. Proposed explanations include pain modulation and biologic effects on nerve and surrounding tissue, but clinical evidence does not demonstrate that shockwave physically enlarges the carpal tunnel.
Radial and focused: a modality audit
Both radial and focused ESWT appear in the carpal tunnel literature, including placebo-controlled trials of each. A double-blind trial of 34 patients (40 wrists) found that three sessions of radial ESWT with night splinting improved pain, Boston questionnaire scores and median-nerve cross-sectional area more than sham with splinting over 12 weeks (Wu, 2016). A placebo-controlled pilot trial of 30 patients found significant improvements in pain, grip strength, symptom severity and distal motor latency after three sessions of focused ESWT, with no such improvement in the sham group at 12 weeks (Gesslbauer, 2021).
| Study | Year | Design | n | CTS severity | Modality | Protocol | Comparator | Clinical outcome | Electrophysiology | Ultrasound | Follow-up | Limitations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wu et al. | 2016 | Double-blind RCT | 34 (40 wrists) | Not stated in abstract | Radial | 3 sessions plus night splint | Sham plus night splint | Better VAS and BCTQ (except severity at week 12) | SNCV measured; not reported as significant in abstract | Smaller CSA (except weeks 1 and 4) | 12 weeks | Small sample |
| Gesslbauer et al. | 2021 | Placebo-controlled pilot RCT | 30 | Mild to moderate | Focused | 3 sessions | Sham | VAS, grip and symptom severity improved; not in sham group | Distal motor latency improved at week 12 | Not assessed | 12 weeks | Pilot; small sample |
| Ghasemi et al. | 2024 | Single-blind RCT | 36 randomized, 18 analyzed | Mild to moderate | Unspecified in abstract | 4 sessions over 2 weeks, plus conventional therapy | Low-level laser plus conventional therapy | Pain improved in both | Not assessed | CSA reduced in both | 2 weeks | 50% attrition; no untreated control |
| Al-Afify et al. | 2026 | RCT | 100 women | Mild to moderate | Radial | 6 weekly sessions, 1 Hz, 60 mJ, 1,200 shocks | Same conventional program without ESWT | Better SSS and VAS; FSS not significant | Better DSL, DML, SNCV; MNCV not significant | Not assessed | 6 weeks | Women aged 25–40; multimodal background |
| Kocaman et al. | 2026 | Three-arm RCT | 54 | Mild to moderate | Unspecified in abstract | ESWT with splint and gliding, with or without taping | Splint and gliding alone | All improved; ESWT plus taping best | ESWT plus taping best | Not assessed | Not stated in abstract | Does not isolate ESWT |
Neither modality has been shown to be universally superior. Protocol selection should follow what was actually studied, and radial protocol settings should not be transferred to focused devices or the reverse. More on the general differences is in radial shockwave and focused shockwave.
Splinting, manual therapy, injection and surgery
Night splinting reduces prolonged wrist positions that may increase carpal-tunnel pressure and remains a standard first-line strategy for many mild-to-moderate presentations.
Manual therapy has meaningful conservative evidence in CTS, but the treatment should be directed by the patient's actual mechanical and neural findings rather than a presumption of generic scar tissue.
Local corticosteroid injection remains an established treatment option. Comparative reviews suggest ESWT may produce similar short-term and potentially better later outcomes in some studies, but certainty is limited.
Carpal-tunnel release remains the definitive mechanical decompression procedure when nerve compression is severe or progressive. Progressive thenar weakness, thenar atrophy, severe electrodiagnostic compression, persistent sensory loss or refractory symptoms call for specialist evaluation rather than more conservative treatment.
What about EMTT?
We searched for human clinical studies of electromagnetic transduction therapy (EMTT) in carpal tunnel syndrome and median nerve entrapment and found none. Pulsed electromagnetic field therapy and peripheral magnetic stimulation are different technologies and are not substitutes. Direct EMTT-specific evidence for carpal tunnel syndrome remains insufficient.
The bottom line
ESWT has a substantial randomized evidence base for mild-to-moderate CTS and appears capable of improving pain, symptom scores, function and selected electrophysiologic or ultrasound measures. The certainty and durability of the effect remain less clear because protocols and comparator treatments vary. ESWT should therefore be positioned as an evidence-supported conservative option—not as a substitute for decompression when progressive motor deficit or severe nerve compression is present.
The overall approach is described on our carpal tunnel and median nerve pain page, and our general shockwave therapy page explains how treatment is selected.
References
- Zhang L, Yang T, Pang L, Li Y, Li T, Zhang C, et al. Effects of extracorporeal shock wave therapy in patients with mild-to-moderate carpal tunnel syndrome: an updated systematic review with meta-analysis. Journal of Clinical Medicine. 2023;12(23):7363. PMID 38068415. (link)
- Chen KT, Chen YP, Kuo YJ, Chiang MH. Extracorporeal shock wave therapy provides limited therapeutic effects on carpal tunnel syndrome: a systematic review and meta-analysis. Medicina (Kaunas). 2022;58(5):677. PMID 35630095. (link)
- Chen Y, Han B, Zhang X, Guo C, Han Q, Zhang Z, et al. Conservative treatments of carpal tunnel syndrome: a systematic review and network meta-analysis. Archives of Physical Medicine and Rehabilitation. 2025;106(9):1447-1458. PMID 40315975. (link)
- Kim JC, Jung SH, Lee SU, Lee SY. Effect of extracorporeal shockwave therapy on carpal tunnel syndrome: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2019;98(33):e16870. PMID 31415424. (link)
- Xie Y, Zhang C, Liang B, Wang J, Wang L, Wan T, et al. Effects of shock wave therapy in patients with carpal tunnel syndrome: a systematic review and meta-analysis. Disability and Rehabilitation. 2022;44(2):177-188. PMID 32419508. (link)
- Al-Afify DH, Saeed D, Zidan FS, Wahba MM, Ghoneim OSA, Sayed ENE, et al. Adding extracorporeal shockwave therapy to conventional treatment improves pain, function, and electrophysiological function in females with carpal tunnel syndrome: a randomized controlled trial. Annals of Rehabilitation Medicine. 2026;50(3):179-187. PMID 42332941. (link)
- Kocaman H, Canli M, Ceylan İ, Valamur İ, Yetiş A, Yildirim H, et al. Investigation of the effectiveness of extracorporeal shock wave therapy and kinesiotaping in individuals with carpal tunnel syndrome: a randomized controlled trial. American Journal of Physical Medicine & Rehabilitation. 2026. PMID 42296467. (link)
- Ghasemi A, Olyaei GR, Bagheri H, Hadian MR, Jalaei S, Otadi K, et al. A randomized clinical trial on the changing of median nerve cross-sectional area and pain after extracorporeal shock wave and low-level laser therapy added to conventional physical therapy in patients with mild-to-moderate carpal tunnel syndrome. Journal of Hand Therapy. 2024;37(4):555-562. PMID 38278695. (link)
- Yang L, Li X, Li S, Yang J, Meng D. Effect of extracorporeal shock wave therapy on nerve conduction: a systematic review and meta-analysis. Frontiers in Neurology. 2024;15:1493692. PMID 39650239. (link)
- Wu YT, Ke MJ, Chou YC, Chang CY, Lin CY, Li TY, et al. Effect of radial shock wave therapy for carpal tunnel syndrome: a prospective randomized, double-blind, placebo-controlled trial. Journal of Orthopaedic Research. 2016;34(6):977-984. PMID 26610183. (link)
- Gesslbauer C, Mickel M, Schuhfried O, Huber D, Keilani M, Crevenna R. Effectiveness of focused extracorporeal shock wave therapy in the treatment of carpal tunnel syndrome: a randomized, placebo-controlled pilot study. Wiener Klinische Wochenschrift. 2021;133(11-12):568-577. PMID 33351153. (link)
